Abbott Diabetes Care
Clinical trials sponsored by Abbott Diabetes Care, explained in plain language.
Develops glucose monitoring devices for diabetes.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Glucose monitor study aims to uncover hidden signs of prediabetes Results expected Dec 2026 (estimated)
- New glucose monitor aims to prevent dangerous low blood sugar in kids Results expected Dec 2026 (estimated)
-
Can a smart sensor beat finger sticks for diabetes control?
Disease control OngoingThis study compares continuous glucose monitoring using the FreeStyle Libre 3 sensor to standard finger-stick testing in 470 adults with type 2 diabetes whose blood sugar is not well controlled. Participants continue their usual medications (basal insulin plus SGLT2 inhibitor and…
Sponsor: Abbott Diabetes Care • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
New glucose monitor aims to prevent dangerous low blood sugar in kids
Disease control OngoingThis study is testing the safety of the FreeStyle Libre 2, a device that continuously checks blood sugar levels, in 550 children and young adults aged 4 to 30 with type 1 or type 2 diabetes. The goal is to see if using this monitor reduces severe low blood sugar events that need …
Sponsor: Abbott Diabetes Care • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC